Development and Licensure of Vaccines to Prevent COVID-19 Guidance for Industry
FDA-2020-D-1137-0121Other
Comments
20
Last activity Aug 28, 2025
Deadline
--
Net supportiSupport minus oppose · campaigns included
0%
0% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Development and Licensure of Vaccines to Prevent COVID-19 Guidance for Industry
- Posted
- Oct 20, 2023
- Comment period
- Oct 20, 2023 – ?
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Analyzed 18 of 20 comments
90%· analysis in progress
Stance breakdown
0%
Net support
Support8Oppose8Other2Not yet analyzed2
Aggregates include form-letter campaigns. Excluding them, net support is 0% across organic comments.
Who commented
Breakdown by commenter type.
Individual
18
Not yet analyzed
2
Comments over time
Weekly arrivals, stacked by stance.
Posted Oct 20, 2023
Dec 4Dec 23Feb 24May 12May 19Jun 9Aug 25
Support8Oppose8Other2
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
44%
44%
11%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- May 23, 2025Comment from Amy LittSupportIndividualRead comment →
- May 21, 2025Comment from Ana BailieSupportIndividual
The commenter supports the proposed guidance by advocating for annual updates to the COVID-19 vaccine, similar to the flu vaccine. They emphasize the importance of providing up-to-date preventative healthcare to all populations, particularly the vulnerable.
Read comment →